Steven Cohen Teva Pharmaceutical Industries LTD Call Options Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $148,320 - $195,082	-20,600 Reduced 34.92%	38,400 $289,000
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $860,243 - $1.17 Million	-102,900 Reduced 63.56%	59,000 $522,000
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $3.51 Million - $4.18 Million	-441,000 Reduced 73.15%	161,900 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $3.43 Million - $5.98 Million	500,000 Added 485.91%	602,900 $4.87 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $2.56 Million - $3.61 Million	-347,100 Reduced 77.13%	102,900 $774,000

Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $3.65 Million - $5.9 Million	450,000 New	450,000 $5.55 Million

543

548M

19.8M

14M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.